| Patents for C07D 475 - Heterocyclic compounds containing pteridine ring systems (2,718) |
|---|
| 03/19/2008 | CN101143863A Resolution for 5-methyltetrahydrofolic acid and salifying method thereof |
| 03/18/2008 | US7345048 Heterocyclic compounds and uses thereof as D-alanyl-D-alanine ligase inhibitors |
| 03/11/2008 | US7341700 Method for recovery of metals from metal-containing materials using medium temperature pressure leaching |
| 03/06/2008 | US20080057005 Hydrogels for the controlled release of bioactive materials |
| 02/27/2008 | EP1891957A1 Purified Compositions of 10-Propargyl-10-Deazaaminopterin and Methods of Using Same in the Treament of Tumors |
| 02/20/2008 | EP1889639A2 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents, for producing long lasting antineoplastic agents |
| 02/19/2008 | US7332553 Functional monomers for molecular recognition and catalysis |
| 02/19/2008 | US7332498 N-(3-amino-propyl)-N-[1-(3-benzyl-4-oxo-3,4-dihydro-pyrido[2,3-d]pyrimidin-2-yl)-2-methyl-propyl]-4-methyl-benzamide; kinesin spindle protein inhibitor; cell division, mitosis phase arrest; antiproliferative and antiinflammation agent, hyperplasias, restenosis, cardiac hypertrophy, autoimmune disorders |
| 02/19/2008 | US7332491 cyclin-dependent and serine/threonine kinases inhibitor; cell cycle arrest in the G2/M phase; antiproliferative and antitumor agent: leukemia, sarcoma, lung, breast, prostate, pancreas cancer; autoimmune diseases: arthritis, Alzheimer's disease |
| 02/14/2008 | US20080038191 Radiolabeled Compounds And Compositions, Their Precursors And Methods For Their Production |
| 02/12/2008 | US7329748 Method for the production of riboflavin of modification b/c in granular form |
| 02/07/2008 | US20080033172 Mutagenic Heterocycles |
| 01/31/2008 | US20080027062 2-amino-4-N-cyclohexylmethylamino-6-(L-erythro-1,2-dihydroxypropyl)-7,8-dihydro-pteridine; treatment of pathological blood pressure decreases, such as occur in septic or hemorrhagic shock, in tumor or cancer therapy with cytokines, liver cirrhosis; ulcerative colitis; NO synthase inhibitor |
| 01/30/2008 | EP1881834A1 Pteridines useful as hcv inhibitors and methods for the preparation thereof |
| 01/24/2008 | WO2008009909A1 Pteridimones as modulators of polo-like kinase |
| 01/24/2008 | US20080021050 Compounds, compositions, and methods |
| 01/23/2008 | EP1880736A1 Releasable linkage and composition containing same |
| 01/09/2008 | EP1874774A1 Combination product |
| 12/27/2007 | US20070298123 Anti-angiogenic compositions and methods of use |
| 12/27/2007 | US20070297976 Metal Ion-Labeled Bis-Aminoethanethiol-Targeting Ligand Conjugates, Compositions, and Methods for Tissue-Specific Imaging |
| 12/26/2007 | EP1869048A1 Method for producing alpha form crystals of sapropterin hydrochloride |
| 12/26/2007 | EP1761536B1 Novel 2-benzylaminodihydropteridinones, method for producing them and use thereof as drugs |
| 12/26/2007 | CN101092416A Derivative of folacin alkylation and application |
| 12/20/2007 | US20070293500 Quinazoline derivatives as medicaments |
| 12/19/2007 | EP1866311A2 Novel compounds |
| 12/13/2007 | US20070287704 7-amino-6-chloro-2-piperazin-1-yl-4-pyrrolidin-1-yl-pteridine; central nervous system, respiratory, gastrointestinal or inflammatory diseases; joints, skin or eyes diseases; cancer; phosphodiesterase 4 inhibitors |
| 12/12/2007 | EP1863816A2 Synthesis and purification of pteroic acid and conjugates thereof |
| 12/12/2007 | CN101087791A Method for producing L-biopterin |
| 12/06/2007 | US20070282100 Boronic ester and acid compounds, synthesis and uses |
| 11/29/2007 | WO2007135374A1 Dihydropteridine compounds as anti proliferative agents |
| 11/29/2007 | WO2007135027A1 Substituted pteridines substituted with a four-membered heterocycle |
| 11/29/2007 | CA2653117A1 Substituted pteridines substituted with a four-membered heterocycle |
| 11/29/2007 | CA2652840A1 2-piperazino-6-chloro-pteridines as pde4-inhibitors for the treatment of inflammatory diseases |
| 11/28/2007 | CN100351242C Processes and intermediates for preparing anti-cancer compounds |
| 11/22/2007 | US20070270441 Combination |
| 11/22/2007 | US20070269380 Methotrexate-modified nanoparticles and related methods |
| 11/22/2007 | US20070267968 Electronic devices made with electron transport and/or anti-quenching layers |
| 11/21/2007 | EP1330440B1 Agent which inactivates pathogens, comprising an element that bonds with nucleic acids and the use thereof |
| 11/15/2007 | WO2007110340A3 Pyrimidine, quinazoline, pteridine and triazine derivatives |
| 11/15/2007 | US20070265444 Novel Inhibitors of Folic Acid-Dependent Enzymes |
| 11/08/2007 | WO2007127366A2 Kinase inhibitors and methods of use thereof |
| 11/08/2007 | US20070259876 3-(2,4-Diaminopteridin-6-yl)phenol or 6-(1H-Indol-4-yl)pteridine-2,4-diamine;phosphoinositide 3-kinase; enzyme inhibitors; vasculostatic agents; antiinflammatory agents; antiarthric agents; transplant rejecction; autoimmune diseases; anticarcinogenic agents |
| 10/31/2007 | CN101065382A Substituted pteridines for treating inflammatory diseases |
| 10/31/2007 | CN101065381A Process for the manufacture of fused piperazin-2-one derivatives |
| 10/31/2007 | CN100345847C Novel biarylcarboxamides |
| 10/25/2007 | WO2007119889A1 Novel piperazine compound, and use thereof as hcv polymerase inhibitor |
| 10/25/2007 | WO2007119367A1 Composition containing biopterin and method for using the same |
| 10/24/2007 | EP1658081B1 Immunosuppressive effects of pteridine derivatives |
| 10/23/2007 | US7285622 Hydrophilic polymer covalently yet reversibly linked to a amine-containing ligand through a dithiobenzyl linkage; modification of various substrates, such as polypeptides |
| 10/18/2007 | US20070244322 Process for Preparing Tetrahydrobiopterin and Analogs of Tetrahydrobiopterin |
| 10/16/2007 | US7282575 Functional peptide nucleic acid monomer and process for producing the same |
| 10/16/2007 | CA2233312C Active oxygen scavengers containing pterin derivatives |
| 10/11/2007 | WO2007090844A8 Trihydrochloride forms of a dihydropteridinone derivative and processes for preparation |
| 10/04/2007 | CA2648025A1 Pyrimidine, quinazoline, pteridine and triazine derivatives |
| 10/02/2007 | US7276506 2-amino-4-ethoxy-6-(4-methoxyphenyl)-pteridine for example; treating transplant rejection, certain inflammatory diseases, cardiovascular disorders, nervous system disorders and cell proliferative disorders |
| 10/02/2007 | US7276248 Conjugate having a cleavable linkage for use in a liposome |
| 10/02/2007 | CA2378369C Small molecules useful in the treatment of inflammatory disease |
| 09/20/2007 | WO2007105023A1 Modulation of phosphoryl transferase activity of glutamine synthetase |
| 09/20/2007 | US20070219204 Pharmaceutically active ornitihine derivatives, ammonium salts thereof and methods of making same |
| 09/20/2007 | US20070219203 Arylalkylamino-substituted quinazoline analogues |
| 09/13/2007 | US20070213531 Process for the Manufacture of fused piperazin-2-one derivatives |
| 09/13/2007 | US20070213530 Intermediate Compounds for the Manufacture of fused piperazin-2-one derivatives |
| 09/12/2007 | EP1831223A1 Method for producing l-biopterin |
| 09/12/2007 | CN100336814C Method for preparing spherical crystal lactochrome utilizing solvent supersonic synergetic effect |
| 09/06/2007 | US20070208027 Intermediate compounds for the manufacture of fused piperazin-2-one derivatives |
| 09/05/2007 | EP1828189A1 Substituted pteridines for treating inflammatory diseases |
| 09/05/2007 | EP1828186A1 Pyrido pyrimidinones, dihydro pyrimido pyrimidinones and pteridinones useful as raf kinase inhibitors |
| 09/05/2007 | CN101031568A Compounds and compositions as protein kinase inhibitors |
| 09/04/2007 | US7265378 Light emitting diodes |
| 08/30/2007 | US20070203146 Specific salt, anhydrous and crystalline form of a dihydropteridione derivative |
| 08/29/2007 | EP1824854A2 Substituted pteridines for treating inflammatory diseases |
| 08/29/2007 | CN100334087C Method for the production of riboflavin of modification B/C in granular form |
| 08/23/2007 | US20070197465 Hyaluronic Acid-Methotrexate Conjugate |
| 08/23/2007 | US20070194698 Charge transport compositions and electronic devices made with such compositions |
| 08/22/2007 | EP1819708A2 Substituted pteridines for treating inflammatory diseases |
| 08/22/2007 | EP1819707A2 Substituted pteridines for the treatment of inflammatory diseases |
| 08/22/2007 | EP1819706A1 Method for producing annelated piperazin-2-one derivatives and intermediates of said method |
| 08/16/2007 | WO2007090844A1 Trihydrochloride forms of a dihydropteridinone derivative and processes for preparation |
| 08/16/2007 | CA2635834A1 Trihydrochloride forms of a dihydropteridinone derivative and processes for preparation |
| 08/15/2007 | EP1673092B1 Heterocycle-substituted pteridine derivatives and their use in therapy |
| 08/15/2007 | EP1663244B1 Pteridine derivatives for the treatment of tnf-alpha-related diseases. |
| 08/09/2007 | WO2007089538A1 Methods and compositions for the production of high concentration alloxazine solutions |
| 08/09/2007 | CA2631162A1 Methods and compositions for the production of high concentration alloxazine solutions |
| 08/08/2007 | CN1330309C Preventives or remedies for diseases caused by e NOS expression |
| 08/02/2007 | US20070179294 convert O-functionalized indazolinone-derivatives to the corresponding N2-functionalized indazolinone derivatives, by use of microwave energy; library for use to screen comounds having 5-lipoxygenase inhibition, aldose reductase inhibition or HIV protease inhibition activity to treat rhematic arthritis |
| 08/02/2007 | US20070179145 Methotrexate orotate; improve bioavailability and drug clearance thereby reducing toxicity in cancer patients and in non-infectious, non-neoplastic inflammatory conditions such as rheumatoid arthritis, psoriasis, systemic lupus, and multiple sclerosis |
| 08/01/2007 | EP1419158B1 Pteridinone derivatives as modulators of chemokine receptor activity |
| 07/25/2007 | CN101006090A Hydrates and polymorphs of 4-[[(7r)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-4-6-oxo-2-piperidinyl]amino]-3-methoxy-n-(1-methyl-4-piperidinyl)-benzamide, methods for the production thereof |
| 07/17/2007 | CA2187186C Stable aqueous folinate solution |
| 07/11/2007 | CN1325480C Novel phenylalanine derivatives |
| 07/10/2007 | US7241889 2-Amino-5-formyl-substituted, e.g., 2-[p-(cyclopropylaminocarbonyl)phenyl]-5-formyl-8-isopentyl--7-methyl-5,6,7,8-tetrahydropteridine; antiproliferative agents |
| 07/10/2007 | CA2380072C Nicotine in therapeutic angiogenesis and vasculogenesis |
| 07/05/2007 | US20070155752 2-Amino-o4-substituted pteridines and their use as inactivators of o6-alkylguanine-dna alkyltransferase |
| 07/04/2007 | CN1324029C Amino biological pterin derivative and pharmaceutical use thereof |
| 07/04/2007 | CN1323666C Stabilized aqueuos folic acid preparation and its production |
| 07/03/2007 | US7238807 Hydrogenating a nitropyrimidine derivative with hydrogen in the presence of a hydrogenation catalyst, adding a copper, iron or vanadium compound to produce 7,8-dihydro-5H-pteridin-6-one derivatives |
| 06/28/2007 | WO2006091885A3 A registry method and control system for dea schedule ii-v medicines |
| 06/28/2007 | US20070149563 N-(1-Azabicyclo[2.2.2]oct-3-yl)(2-(3-pyridyl)thiazole-4-carboxamide); nicotinic acetylcholine receptor ligands; psychotic and intellectual impairment disorders; antidepressant, anxiolytic agent; Alzheimer's disease, cognitive or attention disorders |
| 06/26/2007 | US7235660 Reacting folic acid with hexamethyldisilazane in tertiary amine solvent; or, if using acid catalyst comprising ammonium chloride, sulfate or formate, pyridinium p-toluenesulfonate or hydrochloride or N-methylanilinium trifluoroacetate using a basic solvent or acetonitrile; adding water; amination |
| 06/21/2007 | US20070142387 Process for producing folic acid derivatives |